Back to search

Article

An inherent T cell-activating mRNA delivery platform for <i>in vivo</i> CAR T generation

2025-11-20

Abstract excerpt

The clinical success of CAR T cell therapy has underscored the need for scalable, non-invasive strategies for in vivo T cell engineering. Although mRNA delivery offers a promising alternative, current lipid-based vectors lack intrinsic T cell tropism and often rely on antibody conjugation, complicating manufacturing and raising safety concerns. Here we present an inherent T cell-activating polymer–lipid nanoparti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d06895ce-a0f4-5c0c-9734-e97fea9b41ee
DOI
10.1101/2025.11.19.688592
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An inherent T cell-activating mRNA delivery platform for <i>in vivo</i> CAR T generationDOI 10.1101/2025.11.19.688592
Select a neighboring publication to make it the new centre.